{"product_id":"anesthesia-complications-in-the-dental-office-9780470960295","title":"Anesthesia Complications in the Dental Office","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eAnesthetic complications, which range from simple annoyances to patient mortality,  are inevitable, given the many and complex interactions of doctor, patient, personnel, and facility.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eContributors ix\u003c\/p\u003e \u003cp\u003eForeword xiii\u003c\/p\u003e \u003cp\u003ePreface xv\u003c\/p\u003e \u003cp\u003eAcknowledgment xvii\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1: Introduction\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Anesthetic complications—how bad things happen 3\u003cbr\u003e\u003ci\u003eRobert C. Bosack\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2: Patient risk assessment\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e2 History and physical evaluation 9\u003cbr\u003e\u003ci\u003eKyle Kramer, Trevor Treasure, Charles Kates, Carrie Klene and Jeffrey Bennett\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Laboratory evaluation 15\u003cbr\u003e\u003ci\u003eKyle Kramer and Jeffrey Bennett\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 NPO guidelines 19\u003cbr\u003e\u003ci\u003eKyle Kramer and Jeffrey Bennett\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 3: Anesthetic considerations for special patients\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e5 Anesthetic considerations for patients with cardiovascular disease 25\u003cbr\u003e\u003ci\u003eErik Anderson and Robert Bosack\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Anesthetic considerations for patients with respiratory disease 49\u003cbr\u003e\u003ci\u003eRobert C. Bosack and Zak Messieha\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Anesthetic considerations for patients with endocrinopathies 61\u003cbr\u003e\u003ci\u003eDaniel Sarasin Kevin McCann and Robert Bosack\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Anesthetic considerations for patients with psychiatric illness 71\u003cbr\u003e\u003ci\u003eDaniel L. Orr, Robert C. Bosack and John Meiszner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Anesthetic considerations for patients with neurologic disease 79\u003cbr\u003e\u003ci\u003eJoseph A. Giovannitti\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Anesthetic considerations for patients with hepatic disease 85\u003cbr\u003e\u003ci\u003eJeffrey Miller and Stuart Lieblich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Anesthetic considerations for patients with renal disease 89\u003cbr\u003e\u003ci\u003eMarci H. Levine and Andrea Schreiber\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Anesthetic considerations for pediatric patients 93\u003cbr\u003e\u003ci\u003eMichael Rollert and Morton Rosenberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Anesthetic considerations for geriatric patients 97\u003cbr\u003e\u003ci\u003eAndrea Schreiber and Peter M. Tan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Anesthetic considerations for patients with bleeding disorders 103\u003cbr\u003e\u003ci\u003eO. Ross Beirne\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Anesthetic considerations for patients with cancer 113\u003cbr\u003eAndrea M. Fonner and Robert C. Bosack\u003c\/p\u003e \u003cp\u003e16 Anesthetic considerations for pregnant and early postpartum patients 117\u003cbr\u003eRobert C. Bosack\u003c\/p\u003e \u003cp\u003eSection 4: Review of anesthetic agents\u003c\/p\u003e \u003cp\u003e17 Clinical principles of anesthetic pharmacology 123\u003cbr\u003eRichard C. Robert\u003c\/p\u003e \u003cp\u003e18 Local anesthetic pharmacology 129\u003cbr\u003eRoy L. Stevens and Robert C. Bosack\u003c\/p\u003e \u003cp\u003e19 Enteral sedation agents 133\u003cbr\u003eRichard C. Robert\u003c\/p\u003e \u003cp\u003e20 Parenteral anesthetic agents 135\u003cbr\u003eRichard C. Robert\u003c\/p\u003e \u003cp\u003e21 Inhalational anesthetic agents 143\u003cbr\u003eCharles Kates, Douglas Anderson, Richard Shamo and Robert Bosack\u003c\/p\u003e \u003cp\u003e22 Antimuscarinics and antihistamines 151\u003cbr\u003eRichard C. Robert\u003c\/p\u003e \u003cp\u003e23 Drug interactions 155\u003cbr\u003eKyle Kramer and Richard C. Robert\u003c\/p\u003e \u003cp\u003eSection 5: Monitoring\u003c\/p\u003e \u003cp\u003e24 Limitations of patient monitoring during office-based anesthesia 163\u003cbr\u003eRobert C. Bosack and Ken Lee\u003c\/p\u003e \u003cp\u003eSection 6: Preparation for adversity\u003c\/p\u003e \u003cp\u003e25 Crisis resource management 173\u003cbr\u003eJoseph Kras\u003c\/p\u003e \u003cp\u003e26 Simulation in dental anesthesia 177\u003cbr\u003eJoseph Kras\u003c\/p\u003e \u003cp\u003e27 Airway adjuncts 181\u003cbr\u003eH.William Gottschalk\u003c\/p\u003e \u003cp\u003e28 Intravenous fluids 185\u003cbr\u003eCara Riley, Kyle Kramer and Jeffrey Bennett\u003c\/p\u003e \u003cp\u003e29 Emergency drugs 189\u003cbr\u003eDaniel A. Haas\u003c\/p\u003e \u003cp\u003eSection 7: Anesthetic adversity\u003c\/p\u003e \u003cp\u003e30 Failed sedation 201\u003cbr\u003eRoy L. Stevens and Kenneth L. Reed\u003c\/p\u003e \u003cp\u003e31 Complications with the use of local anesthetics 207\u003cbr\u003eM. Anthony Pogrel, Roy L. Stevens, Robert C. Bosack and Timothy Orr\u003c\/p\u003e \u003cp\u003e32 Anesthetic adversity – cardiovascular problems 219\u003cbr\u003eRobert C. Bosack and Edward C. Adlesic\u003c\/p\u003e \u003cp\u003e33 Anesthetic adversity—respiratory problems 231\u003cbr\u003eCharles F. Cangemi, Edward C. Adlesic and Robert C. Bosack\u003c\/p\u003e \u003cp\u003e34 Allergy and anaphylaxis 251\u003cbr\u003eH.William Gottschalk and Robert C. Bosack\u003c\/p\u003e \u003cp\u003e35 Anesthetic adversity–neurologic problems 257\u003cbr\u003eMichael Trofa and Robert C. Bosack\u003c\/p\u003e \u003cp\u003e36 Acute adverse cognitive behavioral and neuromuscular changes 261\u003cbr\u003eEdward Adlesic, Douglas Anderson, Robert Bosack, Daniel L. Orr and Steven Ganzberg\u003c\/p\u003e \u003cp\u003e37 Anesthetic problems involving vasculature 271\u003cbr\u003eStuart Lieblich\u003c\/p\u003e \u003cp\u003eSection 8: Post-anesthetic adversity\u003c\/p\u003e \u003cp\u003e38 Nausea and vomiting 277\u003cbr\u003eEdward Adlesic\u003c\/p\u003e \u003cp\u003e39 Post-anesthetic recall of intraoperative awareness 283\u003cbr\u003eRobert C. Bosack\u003c\/p\u003e \u003cp\u003e40 Delayed awakening from anesthesia 287\u003cbr\u003eStuart E. Lieblich\u003c\/p\u003e \u003cp\u003e41 Safe discharge after office-based anesthesia 291\u003cbr\u003eStuart Lieblich and Peter M. Tan\u003c\/p\u003e \u003cp\u003eSection 9: When bad things happen\u003c\/p\u003e \u003cp\u003e42 Morbidity and mortality 295\u003cbr\u003eLewis Estabrooks\u003c\/p\u003e \u003cp\u003e43 Death in the chair: a dentist’s nightmare 299\u003cbr\u003eGlen Crick\u003c\/p\u003e \u003cp\u003e44 Legal issues of anesthesia complications: risks or malpractice 307\u003cbr\u003eArthur W. Curley\u003c\/p\u003e \u003cp\u003eSection 10: When should you say no\u003c\/p\u003e \u003cp\u003e45 When should you say no? 315\u003cbr\u003eAndrew Herlich and Robert C. Bosack\u003c\/p\u003e \u003cp\u003eSection 11: Appendices\u003c\/p\u003e \u003cp\u003eAppendix A A pilot’s perspective on crisis resource management 323\u003cbr\u003eDavid Yock\u003c\/p\u003e \u003cp\u003eAppendix B Medical emergency manual for the general practitioner 325\u003cbr\u003eRobert C. Bosack\u003c\/p\u003e \u003cp\u003eAppendix C Malignant hyperthermia Q \u0026amp; A 337\u003cbr\u003eEdward C. Adlesic and Steven I. Ganzberg\u003c\/p\u003e \u003cp\u003eIndex 339\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49402467320151,"sku":"9780470960295","price":79.75,"currency_code":"GBP","in_stock":false}],"url":"https:\/\/bookcurl.com\/products\/anesthesia-complications-in-the-dental-office-9780470960295","provider":"Book Curl","version":"1.0","type":"link"}